Word

OXIDIEN PHARMACEUTICALS

Status

Pending

Status Code

688

Status Date

Tuesday, August 27, 2024

Serial Number

98212166

Mark Type

4

Filing Date

Friday, October 6, 2023

Published for Opposition

Tuesday, July 2, 2024

Trademark Owner History

Oxidien Pharmaceuticals, LLC - Owner At Publication

Classifications

5 Pharmaceutical preparations, substances and products for use in nephrology and urology, namely, for the treatment and prevention of kidney-related disease, namely, kidney stones, hyperoxaluria, hyperoxalemia, and chronic kidney disease

35 Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval

42 Pharmaceutical products development; Development of pharmaceutical preparations and medicines; Pharmaceutical research and development; scientific and technological services, namely, research and development of new products for others, and scientific research in the field of pharmaceutics, and scientific laboratory services; medical and pharmacological research services, namely, scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical preparations, and drugs; natural science services, namely, biological research, and chemical analysis of industrial and clinical fluids; medical and scientific research in the field of pharmaceutical preparations, and drugs; clinical testing, namely, scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical preparations, and drugs; product development of probes, reagents and bioassays for industrial and scientific purposes

"PHARMACEUTICALS"

Trademark Events

Oct 10, 2023

New Application Entered

Oct 14, 2023

New Application Office Supplied Data Entered

Jan 10, 2024

Assignment Of Ownership Not Updated Automatically

May 28, 2024

Assigned To Examiner

May 29, 2024

Notification Of Examiners Amendment E-Mailed

May 29, 2024

Approved For Pub - Principal Register

May 29, 2024

Examiners Amendment -Written

May 29, 2024

Examiner's Amendment Entered

May 29, 2024

Examiners Amendment E-Mailed

Jun 12, 2024

Notification Of Notice Of Publication E-Mailed

Jul 2, 2024

Published For Opposition

Jul 2, 2024

Official Gazette Publication Confirmation E-Mailed

Aug 27, 2024

Noa E-Mailed - Sou Required From Applicant